Climb Bio
CLYM
10.71
+0.03
+0.28%
Climb Bio
US · CLYM
#3610 by market cap
Listed 2021
10.71
+0.03
+0.28%
Live - 5344 symbols - heartbeat 296s ago
· 2026-10-08 09:13
Pre-market
10.50
-1.96%
After-hours
10.71
0.00%
- Market cap
- 615.14M
- P/E (TTM)i
- -13.06
- P/Bi
- 2.57
- EPSi
- -0.88
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on CLYM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 4 in the most recent period (2026/Q3).
- Total institutional ownership rose 2.4 percentage points.
Institutional ownership
- Held by institutions
- 109.79% +2.43pp
- Institutions
- 132 +4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund43.72%
VC/PE Fund34.61%
Hedge Fund29.89%
Individual/Insider1.65%
Public Company0.89%
Private Company0.45%
Insurance Company0.14%
Top holders as of 2026-09-28
RA Capital Management, L.P.
21.83% · 12.54M sh
FMR
11.82% · 6.79M sh
Pontifax Venture Capital
9.06% · 5.21M sh
UBS Asset Management
5.93% · 3.40M sh
Braidwell LP
4.87% · 2.80M sh
Adage Capital Management, L.P.
4.36% · 2.51M sh
BlackRock
4.10% · 2.35M sh
T. Rowe Price Group, Inc.
3.70% · 2.13M sh
Cormorant Asset Management, LP
3.67% · 2.11M sh
Frontier Capital Management
3.38% · 1.94M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 11 sells
| Name | Role | Stake |
|---|---|---|
| RA Capital Management, L.P. | -- | 21.83% |
| Stephen Thomas | Director | 0.81% |
| Aoife Brennan | Chief Executive Officer | 0.15% |
| Andrew Levin | Principal Financial Officer & Executive Chairman | 0.12% |
| Emily Pimblett | Principal Accounting Officer | 0.03% |
| Douglas Williams | Chair of Board | -- |
| Kimberlee Drapkin | Independent Director | -- |
| Cindy Driscoll | Officer | -- |
| Alexander Cumbo | Independent Director | -- |
| Susan Altschuller | Chief Financial Officer | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-27 | Andrew Levin | Principal Financial Officer & Executive Chairman | Derivative Exercise and Retained | +70,000 | $1.29–7.89 |
| 2026-09-14 | Stephen Thomas | Director | Automatic Disposition | -100,000 | $13.67 |
| 2026-06-28 | RA Capital Management, L.P. | -- | Other Derivative Acquisition | +70,284 | $13.36 |
| 2026-06-28 | Aoife Brennan | Chief Executive Officer | Derivative Exercise and Sale | -30,902 | $13.17 |
| 2026-06-28 | Aoife Brennan | Chief Executive Officer | Intent to Sell (Form 144) | -30,902 | $13.17 |
| 2026-06-26 | Aoife Brennan | Chief Executive Officer | Derivative Exercise and Retained | +37,848 | -- |
| 2026-06-04 | Douglas Williams | Chair of Board | Other Derivative Acquisition | +40,000 | $10.55 |
| 2026-06-04 | Kimberlee Drapkin | Independent Director | Other Derivative Acquisition | +40,000 | $10.55 |
| 2026-06-04 | RA Capital Management, L.P. | -- | Other Derivative Acquisition | +40,000 | $10.55 |
| 2026-06-04 | Andrew Levin | Principal Financial Officer & Executive Chairman | Other Derivative Acquisition | +40,000 | $10.55 |
| 2026-06-04 | Alexander Cumbo | Independent Director | Other Derivative Acquisition | +40,000 | $10.55 |
| 2026-06-04 | Stephen Thomas | Director | Other Derivative Acquisition | +40,000 | $10.55 |
| 2026-06-04 | Judith Dunn | Independent Director | Other Derivative Acquisition | +40,000 | $10.55 |
| 2026-04-28 | RA Capital Management, L.P. | -- | Other Derivative Acquisition | +2,106,000 | $0.00 |
| 2026-02-25 | Stephen Thomas | Director | Automatic Disposition | -50,000 | $7.00–7.01 |
| 2026-02-24 | Stephen Thomas | Director | Intent to Sell (Form 144) | -50,000 | $6.36 |
| 2026-02-12 | Stephen Thomas | Director | Automatic Disposition | -100,000 | $5.23–5.81 |
| 2026-02-11 | Stephen Thomas | Director | Intent to Sell (Form 144) | -100,000 | $5.56 |
| 2026-01-05 | Cindy Driscoll | Officer | Other Derivative Acquisition | +100,000 | $3.81 |
| 2026-01-05 | Aoife Brennan | Chief Executive Officer | Other Derivative Acquisition | +700,000 | $3.81 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:13:14 · For reference only, not investment advice and not tailored to your situation.